Crinetics PharmaceuticalsCRNX

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Dr. R. Scott Struthers, PhD

$4.2B

Market Cap • 25/07/2024

2008

(há 16 anos)
Fundação

2018

(6 years ago)
IPO

NASDAQ

Listagem
Flag of US

San Diego

Sede • California

210

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

CRNXSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-0%

1 dia

22/07/2024

2%

1 semana

18/07/2024

19%

1 mês

25/06/2024

187%

1 ano

25/07/2023

139%

5 anos

25/07/2019

10 anos

Histórico